Nutex Health (NUTX) Receivables (2010 - 2026)

Nutex Health (NUTX) has 17 years of Receivables data on file, last reported at $339.6 million in Q1 2026.

• Quarterly Receivables rose 7796.74% year-over-year to $339.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $339.6 million (up 7796.74% YoY) and the FY2025 annual result came in at $6.0 million, up 66.57% from the prior year.
• Receivables climbed to $339.6 million in Q1 2026 per NUTX's latest filing, from $6.0 million in the prior quarter.
• The five-year high for Receivables was $339.6 million in Q1 2026, with the low at $685428.0 in Q1 2022.
• Average Receivables over 5 years is $41.3 million, with a median of $5.7 million recorded in 2025.
• Year-over-year, Receivables jumped 28525.17% in 2022 and tumbled 98.64% in 2023.
• Nutex Health's Receivables stood at $58.3 million in 2022, then rose by 0.45% to $58.6 million in 2023, then slumped by 93.85% to $3.6 million in 2024, then soared by 66.57% to $6.0 million in 2025, then soared by 5559.33% to $339.6 million in 2026.
• Business Quant data shows NUTX's Receivables at $339.6 million in Q1 2026, $6.0 million in Q4 2025, and $7.3 million in Q3 2025.